Scientist III / Senior Scientist, Immuno-Oncology Research

This job is no longer active. View similar jobs.

POST DATE 9/3/2016
END DATE 11/12/2016

Five Prime Therapeutics, Inc. South San Francisco, CA

South San Francisco, CA
AJE Ref #
Job Classification
Full Time
Job Type
Company Ref #
Entry Level (0 - 2 years)


div id="contentwrapper" p strong Five Prime Therapeutics, Inc.  /strong (NASDAQ: FPRX) is a publicly traded, clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics for patients with serious unmet medical needs. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. /p p We currently have three protein therapeutics in clinical trials: /p ul li FPA008: a monoclonal antibody that inhibits the CSF-1 receptor and is being studied in multiple tumor settings and pigmented villonodular synovitis (PVNS) /li li FPA144: a monoclonal antibody targeting FGFR2b for selected gastric cancers /li li FP-1039: a FGF ligand trap for mesothelioma /li /ul p On the strength of our unique discovery platform and capabilities, we have entered into strategic collaborations with leading global pharmaceutical companies.  We currently have three active research collaborations with Bristol-Myers Squibb, GlaxoSmithKline and UCB Pharma, S.A. /p p Five Prime is committed to innovation and outstanding science to develop effective new drugs for the treatment of severe diseases. These values are reflected in our people and our products. We value our culture of openness, collaboration and productivity. Discover more about FivePrime at /p h2 The Position /h2 p We are currently seeking a highly motivated and innovative Scientist III/Senior Scientist to join our Immuno-Oncology group.  The candidate will be an expert in the field of cancer immunology and will be in charge of identifying and validating novel cancer immune therapeutics.  This individual will lead projects and be responsible for progressing therapeutic candidates from Discovery to IND-enabling studies.  He/she will be expected to identify new cancer immunotherapy targets and to implement program strategies with clear go/no go decision points and objective timelines.  The ideal candidate will have significant experience leading projects preferentially in an industry setting. The candidate will have an extensive background in immunology with particular emphasis on T cells and cancer.  /p